| Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study T Tuylu, I Sari, D Solmaz, DL Kozaci, S Akar, N Gunay, F Onen, N Akkoc Clinics 69, 688-693, 2014 | 30 | 2014 |
| Chordoma: a case series and review of the literature O Alan, T Akin Telli, O Ercelep, E Tanrikulu Simsek, T Basoglu Tuylu, ... Journal of Medical Case Reports 12, 1-5, 2018 | 26 | 2018 |
| Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment? O Alan, T Akin Telli, B Aktas, S Koca, IN Ökten, R Hasanov, T Basoglu, ... World Journal of Surgical Oncology 18, 1-9, 2020 | 19 | 2020 |
| How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature O Alan, O Kuzhan, S Koca, TA Telli, T Basoglu, O Ercelep, D Filinte, ... Journal of Oncology Pharmacy Practice 26 (4), 1011-1018, 2020 | 17 | 2020 |
| VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: a case series with review of the literature TA Telli, IN Okten, TB Tuylu, NC Demircan, R Arikan, O Alan, O Ercelep, ... Current Problems in Cancer 44 (5), 100568, 2020 | 10 | 2020 |
| Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line … NC Demircan, Ö Alan, T Başoğlu Tüylü, T Akın Telli, R Arıkan, FC Cicek, ... Journal of Oncology Pharmacy Practice 26 (5), 1147-1155, 2020 | 10 | 2020 |
| A rare case of primary rectal choriocarcinoma and review of the literature TA Telli, NC Demircan, O Alan, TB Tuylu, R Arikan, O Ercelep, AE Atıcı, ... Journal of Oncology Pharmacy Practice 26 (4), 989-994, 2020 | 9 | 2020 |
| Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer O Ercelep, O Alan, D Sahin, TA Telli, H Salva, TB Tuylu, NA Babacan, ... Clinical and Translational Oncology 21, 499-504, 2019 | 7 | 2019 |
| Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma O Ercelep, O Alan, TA Telli, TB Tuylu, R Arıkan, NC Demircan, ET Simsek, ... Tumori Journal 107 (3), 231-237, 2021 | 6 | 2021 |
| A rare case of gastric cancer with bilateral breast metastasis during pregnancy T Basoglu, TA Telli, NC Demircan, R Arikan, O Ercelep, S Ozguven, ... Journal of Oncology Pharmacy Practice 27 (1), 220-226, 2021 | 5 | 2021 |
| Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study B Bilgin, MAN Sendur, S Yucel, E Celik, DT Ozyukseler, M Ayhan, ... Journal of Cancer Research and Clinical Oncology 147, 2145-2152, 2021 | 4 | 2021 |
| Kadýnlarda Tip 2 Diyabet Geliþimine Emzirme Süresinin Etkisi/The effects of the period of breast feeding on the development of Type 2 diabetes in women B İnal, B Karadag, G Hitay, S Küçükmen, T Hacibekiroglu, TB Tüylü, ... Şişli Etfal Hastanesi Tip Bülteni 49 (1), 11, 2015 | 4 | 2015 |
| Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving … TA Telli, S Ozguven, O Alan, N Filizoglu, MA Ozturk, N Sariyar, S Isik, ... Annals of Nuclear Medicine 36 (11), 964-975, 2022 | 3 | 2022 |
| Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters R Arikan, S Ozguven, TA Telli, S Isik, NC Demircan, T Basoglu, A Yasar, ... Acta Radiologica 64 (5), 2040-2049, 2023 | 2 | 2023 |
| Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma T Basoglu, NA Babacan, FE Ozturk, R Arikan, NC Demircan, TA Telli, ... Indian Journal of Cancer 60 (2), 179-184, 2023 | 2 | 2023 |
| A Laboratory Prognostic Index Model for Predicting Survival in Patients with Malignant Pleural Mesothelioma. T Basoglu, NC Demircan, TK Gunes, MU Capar, M Cinar, R Arikan, ... Eurasian Journal of Medical Investigation 6 (3), 2022 | 2 | 2022 |
| Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study I Cil, A Kucukarda, MM Atcı, S Secmeler, N Paksoy, F Ferhatoglu, N Ak, ... Tumori Journal 108 (1), 19-25, 2022 | 2 | 2022 |
| Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience O Alan, TA Telli, TB Tuylu, R Arikan, NC Demircan, O Ercelep, S Kaya, ... Journal of Oncology Pharmacy Practice 27 (2), 329-339, 2021 | 2 | 2021 |
| Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the palliative care working committee of the Turkish Oncology … A Alkan, A Yaşar, ZG Güç, M Gürbüz, T Başoğlu, SS Göksu, FB Başal, ... Annals of Oncology 30, v667, 2019 | 2 | 2019 |
| Age-adjusted Charlson comorbidity index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities TA Telli, O Alan, NC Demircan, N Sariyar, R Arikan, T Basoglu, A Yasar, ... Orthopaedics & Traumatology: Surgery & Research 109 (3), 103491, 2023 | 1 | 2023 |
